ABG
Analyst Note: Asbury Automotive Group, Inc. (ABG)
Date: 2026-06-13 Current Price: $197.05
1. Structural Readiness
State: Forming Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone; requires confirmation) Breakout Level: — (Pending confirmation) Current Price: $197.05 Extension: — Coil Classification: FORMING
2. Thesis Layer
Thesis Status: TACTICAL (Setup-Led) Macro Thesis: None named at this date. Analysis: This is a tactical, setup-led name. There is no named secular macro thesis driving the immediate setup. The conviction must be derived strictly from the quality of the structural setup (the forming coil) combined with the underlying business fundamentals and management execution. Do not invent a macro narrative; judge the name on the strength of the operational turnaround and the technical structure.
3. Business Overview
Company Profile: Asbury Automotive Group, Inc. operates as a leading retailer of new and used vehicles, parts, and service, alongside finance and insurance (F&I) products. Industry: Consumer Discretionary / Automotive Retail. Operational Scope:
- Footprint: As of the most recent filings (May 2026), the company owned and operated 202 new vehicle franchises across 158 dealership locations in 14 states, covering 34 brands. This represents a consolidation from 223 franchises in December 2025, following a strategic divestiture of 10 dealerships and a collision center (approx. $600M annualized revenue) to optimize the portfolio (Evidence E4, E9).
- Product Mix: The new vehicle revenue brand mix consists of 40% imports, 35% luxury, and 26% domestic brands (Evidence E11).
- Service & F&I: The company operates 37 collision centers and its proprietary F&I product provider, Total Care Auto, Powered by Asbury (TCA). TCA rollout was completed in Florida and the Koons platform in 2025, with a target to complete rollout to the Herb Chambers platform in 2026 (Evidence E17).
Management Expectations & Execution (Source: Q1 2026 Earnings, April 28, 2026):
- Tekion Platform: Over 50% of stores are running on the Tekion technology platform, with management expecting full conversion by the fall of 2026 (Evidence E1). Management anticipates beginning to fully realize cost and efficiency benefits post-conversion (Evidence E2).
- Operational Efficiency: Q1 and Q2 2026 represented a peak in store count during the transition. Specific March data showed gross dollars per technician up 21% year-over-year and average productivity per service advisor up 16% (Evidence E5).
- EBITDA Outlook: Management expects fixed operations gross profit to grow at mid-single-digit rates over time. They anticipate EBITDA margins approaching the mid-60s range once Tekion efficiencies are fully integrated, with a dramatic EBITDA improvement expected in the back half of 2026 and into 2027 (Evidence E7, E8).
- Market Context: The U.S. SAAR for new vehicle sales was 15.6 million in Q1 2026, down from 16.5 million in Q1 2025. However, the average vehicle age is historically high at 12.8 years, supporting long-term demand for parts and service (Evidence E12, E13).
4. Archetype and Conviction
Archetype: Cyclical Recovery / Margin Inflector Fit: The name fits the "Cyclical Recovery" archetype due to the combination of a recovering service market (driven by high vehicle age) and a significant operational margin inflection point driven by the Tekion platform rollout. The divestiture of lower-quality assets and the acquisition of the Herb Chambers platform (completed July 2025) have positioned the company for a high-margin, high-efficiency operating model.
Conviction Stack:
- Thesis Strength: Moderate. Lacks a named macro thesis but is supported by strong operational data.
- Evidence Quality: High. Multiple primary sources (earnings transcripts, 10-Q/10-K filings) confirm the transition timeline, efficiency gains, and financial targets.
- Structural Quality: Moderate. The forming coil indicates accumulation or consolidation, but the lack of a confirmed breakout suggests the market is still weighing the execution of the Tekion rollout.
- Valuation Context: Forward consensus EPS is projected at $25.90 for FY1 and $29.25 for FY2 (Evidence E27), suggesting a valuation multiple that prices in significant earnings growth.
- ATR Context: Current ATR is 3.4% (productive). This sits within the "productive" range, indicating sufficient volatility for position sizing without being in the "extreme" (>8%) or "weak" (<2.5%) buckets.
5. Invalidations, Strengths, and Gaps
What Would Strengthen the Case:
- Confirmation of the Tekion rollout completion by the fall of 2026 as stated by management.
- Realization of the "mid-60s" EBITDA margin target in subsequent quarters.
- Continued growth in fixed operations gross profit and technician productivity metrics.
What Would Invalidate the Case:
- Management guidance revision indicating delays in the Tekion rollout or failure to realize efficiency benefits.
- A significant deterioration in the U.S. SAAR or a sharp decline in vehicle age (reducing service demand).
Gaps in Evidence:
- Breakout Confirmation: The specific price level required to confirm the breakout is not yet defined.
- Herb Chambers Integration: While the acquisition is complete, specific synergies or integration costs for the Herb Chambers platform in 2026 are not detailed beyond the rollout timeline.
PRIVATE ANALYST CALL
Judgment: Buy Confidence: medium Key evidence: Tekion platform conversion at >50% with full rollout expected by fall 2026; 21% YoY increase in gross dollars per technician in March 2026; strategic divestiture of $600M revenue to optimize portfolio; forward consensus EPS growth to $29.25 in FY2. Sizing hint: Position size based on current 3.4% ATR volatility; maintain flexibility to add on confirmed breakout. Expected path: Management expects EBITDA to rise dramatically in H2 2026 as Tekion efficiencies run through the system; price likely to consolidate in forming coil before reacting to margin inflection data. Expected horizon: 6 to 12 months (aligned with Tekion rollout completion and H2 2026 earnings).
Chart
Evidence & Catalysts
Source-backed evidence anchors and catalysts land once Convexity finishes coverage for ABG.
Core Assumptions
Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.
Value Picture
Value picture unavailable — no financial spine on file for ABG.
Financial Highlights
Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.